CO6280050A1 - Forma farmaceutica de inhibidores de la fosfodiesterasa para administracion transmucosa - Google Patents

Forma farmaceutica de inhibidores de la fosfodiesterasa para administracion transmucosa

Info

Publication number
CO6280050A1
CO6280050A1 CO10068719A CO10068719A CO6280050A1 CO 6280050 A1 CO6280050 A1 CO 6280050A1 CO 10068719 A CO10068719 A CO 10068719A CO 10068719 A CO10068719 A CO 10068719A CO 6280050 A1 CO6280050 A1 CO 6280050A1
Authority
CO
Colombia
Prior art keywords
pharmaceutical form
phosphodesterase
inhibitors
relates
present
Prior art date
Application number
CO10068719A
Other languages
English (en)
Inventor
Ovalle Jorge Hernando Useche
Zuniga Rafael Martinez
Zarta Cristina Salazar
Original Assignee
Sante S A Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sante S A Lab filed Critical Sante S A Lab
Priority to CO10068719A priority Critical patent/CO6280050A1/es
Publication of CO6280050A1 publication Critical patent/CO6280050A1/es
Priority to MX2012014237A priority patent/MX2012014237A/es
Priority to PCT/IB2011/001415 priority patent/WO2011154830A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a una nueva forma farmacéutica de INHIBIDORES DE LA FOSFODIESTERASA para administración transmucosa. Más particularmente, la presente invención se refiere a unanueva composición farmacéutica líquida de tipo liposomal de INHIBIDORES DE LA FOSFODIESTERASA que contiene citrato de 1 - ((3 - (6,7-dihidro-1-metil-7-oxo-3-propil-1H-pirazolo (4,3-d) pirimidin-5-il)-4-etoxifenil)sulfonil)- 4-metilpiperazina, como agente activo asociado con uno o más excipientes farmacéuticamente aceptables.
CO10068719A 2010-06-08 2010-06-08 Forma farmaceutica de inhibidores de la fosfodiesterasa para administracion transmucosa CO6280050A1 (es)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CO10068719A CO6280050A1 (es) 2010-06-08 2010-06-08 Forma farmaceutica de inhibidores de la fosfodiesterasa para administracion transmucosa
MX2012014237A MX2012014237A (es) 2010-06-08 2011-06-03 Forma farmaceutica de inhibidores de la fosfodiesterasa para administracion transmucosa.
PCT/IB2011/001415 WO2011154830A2 (es) 2010-06-08 2011-06-03 Forma farmaceutica de inhibidores de la fosfodiesterasa para administracion transmucosa

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CO10068719A CO6280050A1 (es) 2010-06-08 2010-06-08 Forma farmaceutica de inhibidores de la fosfodiesterasa para administracion transmucosa

Publications (1)

Publication Number Publication Date
CO6280050A1 true CO6280050A1 (es) 2011-05-20

Family

ID=44084021

Family Applications (1)

Application Number Title Priority Date Filing Date
CO10068719A CO6280050A1 (es) 2010-06-08 2010-06-08 Forma farmaceutica de inhibidores de la fosfodiesterasa para administracion transmucosa

Country Status (3)

Country Link
CO (1) CO6280050A1 (es)
MX (1) MX2012014237A (es)
WO (1) WO2011154830A2 (es)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6548490B1 (en) * 1997-10-28 2003-04-15 Vivus, Inc. Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
US6270806B1 (en) * 1999-03-03 2001-08-07 Elan Pharma International Limited Use of peg-derivatized lipids as surface stabilizers for nanoparticulate compositions
US6610322B1 (en) * 2000-12-20 2003-08-26 Brian Charles Keller Self forming, thermodynamically stable liposomes and their applications
NZ554183A (en) * 2004-10-18 2009-04-30 Polymun Scient Immunbio Forsch Liposomal composition comprising an active ingredient for relaxing smooth muscle production and therapeutically use of said composition
CN101269212B (zh) * 2008-04-30 2013-09-18 上海麟翔生物技术有限公司 一种可吞咽的漱口液

Also Published As

Publication number Publication date
MX2012014237A (es) 2013-01-18
WO2011154830A3 (es) 2012-03-01
WO2011154830A2 (es) 2011-12-15

Similar Documents

Publication Publication Date Title
PH12018501807A1 (en) Pyrazolopyrrolidine derivatives and their use in the treatment of diseas
CR20160191A (es) Compuestos derivados de piridilo bicíclicos fusionados a anillo como inhibidores de fgfr4
MX345928B (es) Composiciones terapeuticamente activas y metodos de uso de las mismas.
MX2015016344A (es) Derivados de imidazo-pirrolidinona y su uso en el tratamiento de enfermedades.
CL2015002608A1 (es) Compuesto de amino-pirazol y usos medicinales relacionados.
UY33536A (es) INHIBIDORES BICÍCLICOS DE ACETIL-CoA-CARBOXILASA Y USOS DE LOS MISMOS
UY35663A (es) Derivados de piperidinil-indol como inhibidores del factor de complemento b y usos de los mismos
BR112015000229A2 (pt) formulações aquosas estáveis de etanercept
CU20160192A7 (es) Derivados de indano e indolina útiles como activadores de la guanilato ciclasa soluble
MX2015016421A (es) Derivados de pirazolo-pirrolidin-4-ona como inhibidores de bet y su uso en el tratamiento de enfermedades.
TN2012000371A1 (en) Pyrazole compounds as crth2 antagonists
UY32816A (es) Formulación farmacéutica a base de 1-[2-(2,1,3-benzotiadiazol-5-ilamino)-6(2,6-diclorofenil)-pirido[2,3-d] pirimidin-7-il]-3-tert-butil-uréa
EA201100358A1 (ru) Дабигатран для чрескожной хирургической катетеризации сердца
CR20150367A (es) Compuestos químicos
CR20140508A (es) Moduladores de la ruta del complemento y usos de los mismos
CO6491060A2 (es) Compuestos y composiciones para el tratamiento de enfermedades parasitarias
CU20150084A7 (es) Derivados del ácido 4-((1,1) bisfenil -4-il)-3-(3-fosfonopropanamido)butanoico,activo como inhibidores de nep(endopeptidasa neutral)
CY1118032T1 (el) Διεργασιες για την εμπορικη παρασκευη φαρμακευτικα δραστικου παραγοντα
UY33348A (es) Compuestos de furopiridina y usos de los mismos
MX2015007940A (es) Compuestos tricíclicos como inhibidores de cftr.
EA201300857A1 (ru) Пиразолы в качестве антагонистов crth2
MX2016006667A (es) Derivados de pirrolo-pirrolona y su uso como inhibidores.
BR112015023078A2 (pt) inibidores de pirrolopirimindina cdk9 quinase
CO6280050A1 (es) Forma farmaceutica de inhibidores de la fosfodiesterasa para administracion transmucosa
PE20150022A1 (es) Dronedarona para uso en la leishmaniosis, formulaciones y asociaciones para uso en la leishmaniosis

Legal Events

Date Code Title Description
FC Application refused